Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications [0.03%]
立体定向身体放射治疗在早期NSCLC中的历史回顾、当代证据及未来意义
Stephen Abel,Shaakir Hasan,Zachary D Horne et al.
Stephen Abel et al.
Clinical use of stereotactic body radiation therapy (SBRT) has increased dramatically over the last 2 decades and is the current standard-of-care in cases of inoperable early stage non-small-cell lung cancer. While surgical resection remain...
Fahad Faruqi,Elizabeth Cathcart-Rake,Kathryn J Ruddy
Fahad Faruqi
Jennifer Straiton
Jennifer Straiton
Targeting claudin-3 suppresses stem cell-like phenotype in nonsquamous non-small-cell lung carcinoma [0.03%]
靶向Claudin-3可抑制非鳞状非小细胞肺癌肿瘤干细胞样表型
Lin Ma,Wu Yin,Heliang Ma et al.
Lin Ma et al.
Aim: To determine the role of claudin-3 in cancer stemness in nonsquamous non-small-cell lung carcinoma (NSCLC). Materials & methods: I...
Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies [0.03%]
免疫检查点抑制疗法中临床反应的系统性免疫生物标志物
Hugo Arasanz,Miren Zuazo,Ruth Vera et al.
Hugo Arasanz et al.
Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series [0.03%]
既往接受过消融治疗后的立体定向放疗：一项单中心病例系列研究
Rodney E Wegner,Nissar Ahmed,Shaakir Hasan et al.
Rodney E Wegner et al.
Aim: Non-small-cell lung cancer recurs locally 10-40% of the time after local therapy, presenting a therapeutic challenge given poor pulmonary reserve. Herein, we seek to evaluate the safety and efficacy of stereotactic b...
Sanjoy Roy
Sanjoy Roy
Sanjoy Roy speaks to Alfie Gleeson, Commissioning Editor: Sanjoy Roy is the Director of Franchise Health Economics and Market Access at Ethicon, Inc. - part of the Johnson and Johnson Medical Device Companies (OH, USA). He has a Bachelor's ...
PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness [0.03%]
18F-FDG PET/CT和脑MRI在NSCLC分期中的作用：一项关于准确度、可靠性和成本效益的前瞻性研究
Vasiliki-Konstantina I Gkogkozotou,Ioannis C Gkiozos,Andriani G Charpidou et al.
Vasiliki-Konstantina I Gkogkozotou et al.
Aim: To determine whether PET/CT and brain MRI used in staging NSCLC can be accurate, reliable and cost-effective tools. NSCLC represents 80-85% of lung cancer and adequate information on the initial tumor staging is crit...
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions [0.03%]
早期肺癌的立体定向放疗：活检证实和经验治疗病灶的结果分析
Rodney E Wegner,Nissar Ahmed,Shaakir Hasan et al.
Rodney E Wegner et al.
Aim: Herein, we compare outcomes in patients treated with lung stereotactic body radiotherapy (SBRT) with and without tissue confirmation. Methods: ...
Joel Mason,Benjamin Blyth,Michael P MacManus et al.
Joel Mason et al.
Surgery is the main curative therapy for patients with localized non-small-cell lung cancer while radiotherapy (RT), alone or with concurrent platinum-based chemotherapy, remains the primary curative modality for locoregionally advanced non...